Bioelectronics is a goldmine cleverly disguised as an

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
408
Bioelectronics is a goldmine cleverly disguised as an economic dumpster fire on the brink of collapse and insolvency which is constantly attacked and denigrated by an army of pathetic bashtards who lack any semblance of rational critical thinking skills. The arguments are insane, stupidly insipid, and shrill. You sick sons-a-bitches couldn’t pass muster in a pre-k, dog&cat, dick&jane spelling bee let alone hold your own in an adult conversation. Your days of bloviating w/o consequence are over. You are pieces of human shit who have willingly sold themselves into intellectual and emotional prostitution.

Our medical system has become a ferocious battle between those who seek medical care that works and those whose moral and ethical depravity is on full display as in the recent senate hearings featuring RFK, Jr. tearing apart those big pharma hyprocrites whose pockets are stuffed w/ the money stolen from the victims of the deliberately malicious and intentionally perpetrated opioid onslaught. These politicians, the CEOs and their lobbyists, the AMA, the vaccine and opioid manufacturers have the blood of millions on their hands. I would hate to be them when they go to meet their Maker. Their judgment will be as swift as it is devastating. God will NOT have mercy on your blood-stained souls.

Bioelectronics has a pain relief product that has not one single recognizable negative side effect in over 20 yrs of use. Name one FDA approved, AMA advertised, big pharma pushed drug that can make the same claim. BIEL’s survival is proof positive of the insanely huge market waiting for them to claim their victory. Within the system there are those people who know full well what is happening. A revolution is taking place as I live and breathe. We, Bioelectronics the company, the loyal shareholders, the general public, the companies who are quietly making the Bioelectronics transition happen, will change the status quo forever. We are the business end of the spear and they fear us. We are coming and they know it. Their efforts to lie, cheat, steal, deceive, defraud, and manipulate are at a fever pitch. Their vane attempts to wrap themselves up in ostentatious displays of philanthropy and righteousness to hide their guilt are shameful and hollow.

Bashtards are the very worst of the sleeziest, real guttersnipes. They openly accuse Dr. Sree Koneru of being a fool as if he so stupid he would jeopardize his career and family to align himself with a presumed sham of a company. Viant, and all those people and institutions who are working w/ them (behind the scenes) know exactly what they are doing. A $200,000 investment for a 1 billion share stake is pocket change for a massive windfall return on investment. You think the CEO is nothing but an inept, money-grubbing bitch? Wait and see, pal, wait and see. We are kicking your ass and you don’t even know the fight is on. You get away with your baseless accusations b/c we lack the social fabric to hold you to account for your actions. Big Pharma is an enemy w/o limits or consequences. Therefore, discretion during preparation is paramount.

I, as an individual, am betting we win. And win big, we shall. I wish all my fellow investors the very same. The personal money gain is only part of the success. Moving forward in a position to help family & friends and knowing I was part of changing life for the better for millions of pain sufferers worldwide is supreme gratification. The battle that has been waged for a hundred years against hapless victims is coming to a Dénouement. Books to read are, Turtles All The Way Down, Dissolving Illusions, and Beauchamp or Pasteur?: A Lost Chapter in the History of Biology. Become part of the solution. What have you done today?

Quote:
THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.

"Sic parvis magna" - Greatness from small beginnings

All the best, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 105

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
Sobi Names Börje Ekholm as Chair Amid New Data

Updated Category News Views 23

An Offbeat Choice for Chair? So, Sobi's gone and picked Börje Ekholm as the proposed Chair of their Board. Now, this might raise some eyebrows out there—Ekholm's no stranger to top roles, having steered the ship at Ericsson. The twist here is usually these Chair announcements hum along without much fanfare, but chuck in Ekholm and you get a bit of buzz—probably...

Continue Reading
ASE Technology Shows Strong Growth in Q3 Financials

Updated Category News Views 35

Taipei's Semiconductor Giant Surging Ahead You wanna talk about growth? ASE Technology Holding Co. just posted some fire results for their third quarter of 2026. Revenues screaming to NT$244,161 million, that's a tidy 44.8% jump year-over-year, and even 27.8% more than they grabbed last quarter. Call me old school, but I do love when a company's financials tell a tale of...

Continue Reading
City National Grows with New Inglewood Branch

Updated Category News Views 44

Inglewood, the New Banking Frontier It's not every day you see a bank banking on Inglewood, so to speak. Yet here we are. City National Bank is setting up shop in this buzzing part of Los Angeles, and it's high time someone paid attention to this vibrant hub. With major players in sports, entertainment, healthcare, and even aerospace calling Inglewood home, there's plenty...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 171

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
Digital Science's Game-Changing Jenni AI Acquisition

Updated Category News Views 198

A Strategic Move in the Research Sector When you're dealing with tech giants and their endless race to corner niche markets, it's the big moves that really catch one's attention. The latest acquisition on the block is Digital Science picking up Jenni AI, a platform trusted by over 8 million students and researchers scattered across 189 countries. Now, that's a hefty user...

Continue Reading
SKE Invigorates IRONWORKS London's Music Vibe With E-Cigs

Updated Category News Views 37

Bringing SKE's Flair to London's Music Scene Well, folks, hold onto your hats—SKE's thrown its weight behind IRONWORKS London, extending its reach deeper into the UK's electronic music scene. This ain't just another gig; we're talking about the second time SKE is flexing its sponsorship muscles in the UK music arena, officially angling for the vape category spotlight....

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 30

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 62

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading
Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Updated Category News Views 39

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Auction of Mortgage Covered Bonds Series 10F and 10G

Updated Category News Views 31

Upcoming Auction for Mortgage Covered Bonds Series 10F and 10G Realkredit Danmark is set to auction significant amounts of mortgage covered bonds, specifically series 10F and 10G. This auction is an integral part of their refinancing strategy for the FlexLån product, aimed for initiation on January 1, 2025. Details of the Auction The exact auction details regarding the...

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 88

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
Catheter Precision Launches Kardionav for Enhanced VT Treatment

Updated Category News Views 113

Catheter Precision Forms Kardionav Joint Venture Catheter Precision, Inc. (NYSE: VTAK) is thrilled to announce the creation of a new joint venture called Kardionav, which aims to revolutionize the management of ventricular tachycardia (VT) through advanced artificial intelligence technologies. This collaboration with Chelak iECG, Inc. marks a significant step forward in...

Continue Reading
Investors Encouraged to Join Fiserv Class Action Lawsuit

Updated Category News Views 265

Investors Urged to Join the Fiserv Class Action Lawsuit In a significant development, investors in Fiserv, Inc. (NYSE: FI) are being encouraged to participate in a class action lawsuit aimed at addressing potential securities fraud that occurred during a designated period. This lawsuit is a critical opportunity for those who hold shares in Fiserv to seek compensation...

Continue Reading
Cicor Group Achieves Impressive 26% Boost in Quarterly Sales

Updated Category News Views 44

Cicor Group Achieves Significant Sales Growth BRONSCHHOFEN - The Cicor Group (SIX Swiss Exchange: CICN), a prominent European electronics manufacturer, has recently announced a remarkable increase in its quarterly sales figures. The company has reported a 26.3% rise, bringing total sales to CHF 120.4 million. Moreover, its year-to-date sales have reached CHF 351.7...

Continue Reading